Skip to main content

Table 4 Reader characterization of lesions before and after evaluation of the HPB phase and change in confidence

From: MRI characterization of focal liver lesions in non-cirrhotic patients: assessment of added value of gadoxetic acid-enhanced hepatobiliary phase imaging

  Reader 1 Avg. confidence Before HPB phase Reader 1 Avg. confidence After HPB phase p value Reader 2 Avg. confidence Before HPB phase Reader 2 Avg. confidence After HPB phase p value
FNH 2.8 2.6 0.2 2.9 2.8 0.4
Adenoma 2.8 2.4 0.1 2.9 2.9 1.0
Hemangioma 2.8 2.7 1.0 2.4 2.8 0.5
Metastasis 3.0 2.9 0.5 2.9 2.9 1.0
Biliary hamartoma 3.0 3.0 1.0 3.0 3.0 1.0
Perfusional abnormality 3.0 2.3 0.2 2.4 2.4 1.0
Abscess 2.0 2.0 1.0 3.0 3.0 1.0
Focal fat 2.7 3 1.0 3.0 3.0 1.0
Angiomyolipoma 3.0 3.0 1.0 3.0 3.0 NA
Dysplastic nodule 2.0 0 NA NA
HCC 1.0 1.0 1.0 NA
Lymphoma NA 3.0 NA